Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Deep Inspiration Breath Hold (Dibh) for Cardiac Sparing in Breast Cancer Radiotherapy Publisher



Farzin M1 ; Garosi M2 ; Rajabpour MV3 ; Golami S4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Science, Tehran, Iran
  2. 2. Radiation oncology department, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Cancer and Radiation Oncology Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran
  4. 4. Radiation oncology department, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Radiation Research Published:2022


Abstract

Background: We aimed to assess the effect of the DIBH plan on cardiac and other organs at risk received dose during radiotherapy in left breast cancer patients. Materials and Methods: The study was carried out on 30 patients with left breast cancer with a history of mastectomy/lumpectomy surgery who were referred to the radiotherapy department of the Cancer Institute of Iran. Each patient underwent computed tomography (CT) simulations in two respiratory phases, including deep inspiration breath-hold (DIBH) and free-breathing (FB). In addition, the dose-volume histograms (DVHs) of the heart, lung, spinal cord, and breast of each respiratory phase were compared. Results: We observed a significantly higher mean of heart dose in FB in both lumpectomy and mastectomy groups (P value<0.05). We also compared the means of V25 and V30 heart between FB and DIBH—for both, the received dose was statistically higher in FB than DIBH. The mean dose received by the lung and spinal cord was higher in FB than DIHB. However, the observed difference was only significant in the lumpectomy group (P value<0.05). Conclusion: The DIBH is a viable method that could be suggested to reduce the mean dose of the heart during left breast cancer radiotherapy. © 2022 Novin Medical Radiation Institute. All rights reserved.